Trials
Search / Trial NCT05639881

Enhancing Immune Health Randomized Controlled Trial

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Dec 2, 2022

Trial Information

Current as of January 17, 2025

Recruiting

Keywords

ClinConnect Summary

The Enhancing Immune Health Randomized Controlled Trial is a research study aimed at helping adults with serious mental illnesses improve their understanding and behaviors related to immune health. The study is exploring a special program designed to teach participants about how to take care of their immune system, which is important for overall health. This trial is currently recruiting participants aged 18 and older who are members of a community mental health agency and have access to the Internet.

To be eligible for the study, participants must have a serious mental illness and be able to provide informed consent, meaning they understand what the study involves and agree to take part. Unfortunately, individuals who have severe cognitive difficulties that prevent them from giving informed consent or who cannot communicate in English cannot participate. Those who join the study can expect to engage in activities that will help them learn about immune health, and their progress will be monitored throughout the trial. This research could provide valuable insights into how to better support the health of individuals with mental illnesses.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 and older
  • Serious mental illness
  • Membership in a collaborating community mental health agency
  • Access to the Internet
  • Able to provide informed consent
  • Exclusion Criteria:
  • Cognitive impairment preventing informed consent
  • Unable to communicate in English

About University Of Illinois At Chicago

The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.

Locations

Chicago, Illinois, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials